Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

International Ring Trial of a High Resolution Targeted Metabolomics and Lipidomics Platform for Serum and Plasma Analysis.

Thompson JW, Adams KJ, Adamski J, Asad Y, Borts D, Bowden JA, Byram G, Dang V, Dunn WB, Fernandez F, Fiehn O, Gaul DA, Hühmer AF, Kalli A, Koal T, Koeniger S, Mandal R, Meier F, Naser FJ, O'Neil D, Pal A, Patti GJ, Pham-Tuan H, Prehn C, Raynaud FI, Shen T, Southam AD, St John-Williams L, Sulek K, Vasilopoulou CG, Viant M, Winder CL, Wishart D, Zhang L, Zheng J, Moseley MA.

Anal Chem. 2019 Nov 19;91(22):14407-14416. doi: 10.1021/acs.analchem.9b02908. Epub 2019 Nov 8.

PMID:
31638379
2.

Trace biomarkers associated with spontaneous preterm birth from the maternal serum metabolome of asymptomatic nulliparous women - parallel case-control studies from the SCOPE cohort.

Souza RT, McKenzie EJ, Jones B, de Seymour JV, Thomas MM, Zarate E, Han TL, McCowan L, Sulek K, Villas-Boas S, Kenny LC, Cecatti JG, Baker PN.

Sci Rep. 2019 Sep 23;9(1):13701. doi: 10.1038/s41598-019-50252-7.

3.

Prevalence of methicillin resistant and mupirocin-resistant Staphylococcus aureus strains among medical students of Medical University in Warsaw

Szymanek-Majchrzak K, Kosiński J, Żak K, Sułek K, Młynarczyk A, Młynarczyk G.

Przegl Epidemiol. 2019;73(1):39-48.

4.

Metabolomic profiling of maternal hair suggests rapid development of intrahepatic cholestasis of pregnancy.

de Seymour JV, Tu S, He X, Zhang H, Han TL, Baker PN, Sulek K.

Metabolomics. 2018 May 26;14(6):79. doi: 10.1007/s11306-018-1371-7.

PMID:
30830343
5.

ADAMTS9 Regulates Skeletal Muscle Insulin Sensitivity Through Extracellular Matrix Alterations.

Graae AS, Grarup N, Ribel-Madsen R, Lystbæk SH, Boesgaard T, Staiger H, Fritsche A, Wellner N, Sulek K, Kjolby M, Backe MB, Chubanava S, Prats C, Serup AK, Birk JB, Dubail J, Gillberg L, Vienberg SG, Nykjær A, Kiens B, Wojtaszewski JFP, Larsen S, Apte SS, Häring HU, Vaag A, Zethelius B, Pedersen O, Treebak JT, Hansen T, Holst B.

Diabetes. 2019 Mar;68(3):502-514. doi: 10.2337/db18-0418. Epub 2019 Jan 9.

6.

Clinical and morphological practices in the diagnosis of transplant-associated microangiopathy: a study on behalf of Transplant Complications Working Party of the EBMT.

Moiseev IS, Tsvetkova T, Aljurf M, Alnounou RM, Bogardt J, Chalandon Y, Drokov MY, Dvirnyk V, Faraci M, Friis LS, Giglio F, Greinix HT, Kornblit BT, Koelper C, Koenecke C, Lewandowski K, Niederwieser D, Passweg JR, Peczynski C, Penack O, Peric Z, Piekarska A, Ronchi PE, Rovo A, Rzepecki P, Scuderi F, Sigrist D, Siitonen SM, Stoelzel F, Sulek K, Tsakiris DA, Wilkowojska U, Duarte RF, Ruutu T, Basak GW.

Bone Marrow Transplant. 2019 Jul;54(7):1022-1028. doi: 10.1038/s41409-018-0374-3. Epub 2018 Oct 25.

PMID:
30361500
7.

Genes controlling the activation of natural killer lymphocytes are epigenetically remodeled in intestinal cells from germ-free mice.

Poupeau A, Garde C, Sulek K, Citirikkaya K, Treebak JT, Arumugam M, Simar D, Olofsson LE, Bäckhed F, Barrès R.

FASEB J. 2019 Feb;33(2):2719-2731. doi: 10.1096/fj.201800787R. Epub 2018 Oct 10.

8.

A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.

Han W, Stella S, Zhang Y, Guo T, Sulek K, Peng-Lundgren L, Montoya G, She Q.

Nucleic Acids Res. 2018 Nov 2;46(19):10319-10330. doi: 10.1093/nar/gky844.

9.

A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects.

Dollerup OL, Christensen B, Svart M, Schmidt MS, Sulek K, Ringgaard S, Stødkilde-Jørgensen H, Møller N, Brenner C, Treebak JT, Jessen N.

Am J Clin Nutr. 2018 Aug 1;108(2):343-353. doi: 10.1093/ajcn/nqy132.

PMID:
29992272
10.

A phase II multicenter study of the anti-CD19 antibody drug conjugate coltuximab ravtansine (SAR3419) in patients with relapsed or refractory diffuse large B-cell lymphoma previously treated with rituximab-based immunotherapy.

Trnĕný M, Verhoef G, Dyer MJ, Ben Yehuda D, Patti C, Canales M, Lopez A, Awan FT, Montgomery PG, Janikova A, Barbui AM, Sulek K, Terol MJ, Radford J, Guidetti A, Di Nicola M, Siraudin L, Hatteville L, Schwab S, Oprea C, Gianni AM.

Haematologica. 2018 Aug;103(8):1351-1358. doi: 10.3324/haematol.2017.168401. Epub 2018 May 10.

11.

Skeletal muscle O-GlcNAc transferase is important for muscle energy homeostasis and whole-body insulin sensitivity.

Shi H, Munk A, Nielsen TS, Daughtry MR, Larsson L, Li S, Høyer KF, Geisler HW, Sulek K, Kjøbsted R, Fisher T, Andersen MM, Shen Z, Hansen UK, England EM, Cheng Z, Højlund K, Wojtaszewski JFP, Yang X, Hulver MW, Helm RF, Treebak JT, Gerrard DE.

Mol Metab. 2018 May;11:160-177. doi: 10.1016/j.molmet.2018.02.010. Epub 2018 Feb 24.

12.

Hepatic NAD+ levels and NAMPT abundance are unaffected during prolonged high-fat diet consumption in C57BL/6JBomTac mice.

Dall M, Penke M, Sulek K, Matz-Soja M, Holst B, Garten A, Kiess W, Treebak JT.

Mol Cell Endocrinol. 2018 Sep 15;473:245-256. doi: 10.1016/j.mce.2018.01.025. Epub 2018 Feb 2.

PMID:
29408602
13.

Analysis of sequential hair segments reflects changes in the metabolome across the trimesters of pregnancy.

Delplancke TDJ, de Seymour JV, Tong C, Sulek K, Xia Y, Zhang H, Han TL, Baker PN.

Sci Rep. 2018 Jan 8;8(1):36. doi: 10.1038/s41598-017-18317-7.

14.

Public spirometry campaign in chronic obstructive pulmonary disease screening - hope or hype?

Korczyński P, Górska K, Jankowski P, Kosiński J, Kudas A, Sułek K, Jankowska M, Jaśkiewicz K, Krenke R.

Adv Respir Med. 2017;85(3):143-150. doi: 10.5603/ARM.2017.0024.

15.

Addition of cladribine to the standard induction treatment improves outcomes in a subset of elderly acute myeloid leukemia patients. Results of a randomized Polish Adult Leukemia Group (PALG) phase II trial.

Pluta A, Robak T, Wrzesien-Kus A, Katarzyna Budziszewska B, Sulek K, Wawrzyniak E, Czemerska M, Zwolinska M, Golos A, Holowiecka-Goral A, Kyrcz-Krzemien S, Piszcz J, Kloczko J, Mordak-Domagala M, Lange A, Razny M, Madry K, Wiktor-Jedrzejczak W, Grosicki S, Butrym A, Kuliczkowski K, Warzocha K, Holowiecki J, Giebel S, Szydlo R, Wierzbowska A.

Am J Hematol. 2017 Apr;92(4):359-366. doi: 10.1002/ajh.24654. Epub 2017 Feb 13.

16.

Use of metabolomics for the identification and validation of clinical biomarkers for preterm birth: Preterm SAMBA.

Cecatti JG, Souza RT, Sulek K, Costa ML, Kenny LC, McCowan LM, Pacagnella RC, Villas-Boas SG, Mayrink J, Passini R Jr, Franchini KG, Baker PN; Preterm SAMBA and SCOPE study groups.

BMC Pregnancy Childbirth. 2016 Aug 8;16(1):212. doi: 10.1186/s12884-016-1006-9.

17.

Sildenafil Therapy Normalizes the Aberrant Metabolomic Profile in the Comt(-/-) Mouse Model of Preeclampsia/Fetal Growth Restriction.

Stanley JL, Sulek K, Andersson IJ, Davidge ST, Kenny LC, Sibley CP, Mandal R, Wishart DS, Broadhurst DI, Baker PN.

Sci Rep. 2015 Dec 15;5:18241. doi: 10.1038/srep18241.

18.

Metabolite Profile of Cervicovaginal Fluids from Early Pregnancy Is Not Predictive of Spontaneous Preterm Birth.

Thomas MM, Sulek K, McKenzie EJ, Jones B, Han TL, Villas-Boas SG, Kenny LC, McCowan LM, Baker PN.

Int J Mol Sci. 2015 Nov 19;16(11):27741-8. doi: 10.3390/ijms161126052.

19.

Assessing the efficacy of allogeneic hematopoietic stem cells transplantation (allo-HSCT) by analyzing survival end points in defined groups of acute myeloid leukemia patients: a retrospective, multicenter Polish Adult Leukemia Group study.

Grosicki S, Holowiecki J, Kuliczkowski K, Skotnicki A, Hellmann A, Kyrcz-Krzemien S, Dmoszynska A, Sułek K, Kloczko J, Jedrzejczak WW, Warzocha K, Zdziarska B, Wierzbowska A, Pluta A, Komarnicki M, Giebel S.

Am J Hematol. 2015 Oct;90(10):904-9. doi: 10.1002/ajh.24113.

20.

Maternal hair metabolome analysis identifies a potential marker of lipid peroxidation in gestational diabetes mellitus.

He X, de Seymour JV, Sulek K, Qi H, Zhang H, Han TL, Villas-Bôas SG, Baker PN.

Acta Diabetol. 2016 Feb;53(1):119-22. doi: 10.1007/s00592-015-0737-9. Epub 2015 Apr 24. No abstract available.

PMID:
25904507
21.

Treatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group study.

Budziszewska BK, Pluta A, Sulek K, Wierzbowska A, Robak T, Giebel S, Holowiecka-Goral A, Sawicki W, Ejduk A, Patkowska E, Manko J, Gajkowska-Kulik J, Piszcz J, Mordak-Domagala M, Madry K, Holowiecki J, Kyrcz-Krzemien S, Nowakowska-Domagala M, Dmoszynska A, Calbecka M, Kloczko J, Wiktor Jędrzejczak W, Lange A, Razny M, Bilinski P, Warzocha K, Lech-Maranda E.

Leuk Lymphoma. 2015;56(8):2331-8. doi: 10.3109/10428194.2014.985672. Epub 2015 Jan 21.

PMID:
25393675
22.

Early pregnancy metabolite profiling discovers a potential biomarker for the subsequent development of gestational diabetes mellitus.

de Seymour JV, Conlon CA, Sulek K, Villas Bôas SG, McCowan LM, Kenny LC, Baker PN.

Acta Diabetol. 2014 Oct;51(5):887-90. doi: 10.1007/s00592-014-0626-7. Epub 2014 Jul 27.

PMID:
25064235
23.

Hair metabolomics: identification of fetal compromise provides proof of concept for biomarker discovery.

Sulek K, Han TL, Villas-Boas SG, Wishart DS, Soh SE, Kwek K, Gluckman PD, Chong YS, Kenny LC, Baker PN.

Theranostics. 2014 Jul 20;4(9):953-9. doi: 10.7150/thno.9265. eCollection 2014.

24.

A combined metabolomic and phylogenetic study reveals putatively prebiotic effects of high molecular weight arabino-oligosaccharides when assessed by in vitro fermentation in bacterial communities derived from humans.

Sulek K, Vigsnaes LK, Schmidt LR, Holck J, Frandsen HL, Smedsgaard J, Skov TH, Meyer AS, Licht TR.

Anaerobe. 2014 Aug;28:68-77. doi: 10.1016/j.anaerobe.2014.05.007. Epub 2014 Jun 4.

25.

Lactobacillus acidophilus NCFM affects vitamin E acetate metabolism and intestinal bile acid signature in monocolonized mice.

Roager HM, Sulek K, Skov K, Frandsen HL, Smedsgaard J, Wilcks A, Skov TH, Villas-Boas SG, Licht TR.

Gut Microbes. 2014 May-Jun;5(3):296-303. doi: 10.4161/gmic.28806. Epub 2014 Apr 9.

26.

Long-term results of the Polish Adult Leukemia Group PALG-CLL2 phase III randomized study comparing cladribine-based combinations in chronic lymphocytic leukemia.

Robak T, Blonski JZ, Gora-Tybor J, Calbecka M, Dwilewicz-Trojaczek J, Boguradzki P, Dmoszynska A, Kowal M, Kloczko J, Piszcz J, Stella-Holowiecka B, Sulek K, Kuliczkowski K, Potoczek S, Warzocha K, Lech-Maranda E, Skotnicki AB, Piotrowska M, Moskwa A, Zawilska K, Jamroziak K.

Leuk Lymphoma. 2014 Mar;55(3):606-10. doi: 10.3109/10428194.2013.809073. Epub 2013 Nov 14.

PMID:
23721512
27.

Immune thrombocytopenia in patients with chronic lymphocytic leukemia treated with cladribine-based regiments or chlorambucil--follow-up of PALG-CLL randomized trials.

Blonski JZ, Robak T, Chojnowski K, Gora-Tybor J, Warzocha K, Ceglarek B, Seferynska I, Calbecka M, Kostyra A, Stella-Holowiecka B, Kloczko J, Dmoszynska A, Kowal M, Lewandowski K, Dwilewicz-Trojaczek J, Wiater E, Kuliczkowski K, Potoczek S, Hellmann A, Mital A, Skotnicki A, Nowak W, Sulek K, Zawilska K, Trelinski J.

Eur J Haematol. 2013 Jul;91(1):1-9. doi: 10.1111/ejh.12112. Epub 2013 Apr 19.

PMID:
23521128
28.

Microbiotas from UC patients display altered metabolism and reduced ability of LAB to colonize mucus.

Vigsnaes LK, van den Abbeele P, Sulek K, Frandsen HL, Steenholdt C, Brynskov J, Vermeiren J, van de Wiele T, Licht TR.

Sci Rep. 2013;3:1110. doi: 10.1038/srep01110. Epub 2013 Jan 23.

29.

Cladribine, but not fludarabine, added to daunorubicin and cytarabine during induction prolongs survival of patients with acute myeloid leukemia: a multicenter, randomized phase III study.

Holowiecki J, Grosicki S, Giebel S, Robak T, Kyrcz-Krzemien S, Kuliczkowski K, Skotnicki AB, Hellmann A, Sulek K, Dmoszynska A, Kloczko J, Jedrzejczak WW, Zdziarska B, Warzocha K, Zawilska K, Komarnicki M, Kielbinski M, Piatkowska-Jakubas B, Wierzbowska A, Wach M, Haus O.

J Clin Oncol. 2012 Jul 10;30(20):2441-8. doi: 10.1200/JCO.2011.37.1286. Epub 2012 Apr 16.

PMID:
22508825
30.

Bortezomib modulates surface CD20 in B-cell malignancies and affects rituximab-mediated complement-dependent cytotoxicity.

Bil J, Winiarska M, Nowis D, Bojarczuk K, Dabrowska-Iwanicka A, Basak GW, Sułek K, Jakobisiak M, Golab J.

Blood. 2010 May 6;115(18):3745-55. doi: 10.1182/blood-2009-09-244129. Epub 2010 Mar 3.

PMID:
20200358
31.

Infectious complications in patients with acute myeloid leukemia treated according to the protocol with daunorubicin and cytarabine with or without addition of cladribine. A multicenter study by the Polish Adult Leukemia Group (PALG).

Lech-Maranda E, Seweryn M, Giebel S, Holowiecki J, Piatkowska-Jakubas B, Wegrzyn J, Skotnicki A, Kielbinski M, Kuliczkowski K, Paluszewska M, Jedrzejczak WW, Dutka M, Hellmann A, Flont M, Zdziarska B, Palynyczko G, Konopka L, Szpila T, Gawronski K, Sulek K, Sokolowski J, Kloczko J, Warzocha K, Robak T.

Int J Infect Dis. 2010 Feb;14(2):e132-40. doi: 10.1016/j.ijid.2009.02.021. Epub 2009 Jul 5.

34.

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

Robak T, Jamroziak K, Gora-Tybor J, Blonski JZ, Kasznicki M, Dwilewicz-Trojaczek J, Wiater E, Zdunczyk A, Dybowicz J, Dmoszynska A, Wojtaszko M, Zdziarska B, Calbecka M, Kostyra A, Hellmann A, Lewandowski K, Stella-Holowiecka B, Sulek K, Gawronski K, Skotnicki AB, Nowak W, Zawilska K, Molendowicz-Portala L, Kloczko J, Sokolowski J, Warzocha K, Seferynska I, Ceglarek B, Konopka L.

Blood. 2007 May 1;109(9):3672-5. Epub 2007 Jan 5.

PMID:
17209059
35.

Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia: report of a prospective, multicenter, randomized trial of the Polish Adult Leukemia Group (PALG CLL2).

Robak T, Blonski JZ, Gora-Tybor J, Jamroziak K, Dwilewicz-Trojaczek J, Tomaszewska A, Konopka L, Ceglarek B, Dmoszynska A, Kowal M, Kloczko J, Stella-Holowiecka B, Sulek K, Calbecka M, Zawilska K, Kuliczkowski K, Skotnicki AB, Warzocha K, Kasznicki M; Polish Leukemia Group (PALG CLL2).

Blood. 2006 Jul 15;108(2):473-9. Epub 2006 Mar 21.

PMID:
16551966
36.
37.

Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).

Robak T, Błoński JZ, Kasznicki M, Góra-Tybor J, Dmoszyńska A, Wojtaszko M, Skotnicki AB, Nowak W, Hellmann A, Lewandowski K, Zdziarska B, Konopka L, Ceglarek B, Dwilewicz-Trojaczek J, Boguradzki P, Kuliczkowski K, Sułek K, Warzocha K.

Med Sci Monit. 2005 Oct;11(10):PI71-9. Epub 2005 Sep 26.

PMID:
16192912
38.

An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma.

Hus I, Dmoszynska A, Manko J, Hus M, Jawniak D, Soroka-Wojtaszko M, Hellmann A, Ciepluch H, Skotnicki A, Wolska-Smolen T, Sulek K, Robak T, Konopka L, Kloczko J.

Br J Cancer. 2004 Nov 29;91(11):1873-9.

39.

Outcome and prognostic factors in advanced Hodgkin's disease treated with high-dose chemotherapy and autologous stem cell transplantation: a study of 341 patients.

Czyz J, Dziadziuszko R, Knopinska-Postuszuy W, Hellmann A, Kachel L, Holowiecki J, Gozdzik J, Hansz J, Avigdor A, Nagler A, Osowiecki M, Walewski J, Mensah P, Jurczak W, Skotnicki A, Sedzimirska M, Lange A, Sawicki W, Sulek K, Wach M, Dmoszynska A, Kus A, Robak T, Warzocha K.

Ann Oncol. 2004 Aug;15(8):1222-30.

PMID:
15277262
40.

Addition of cladribine to daunorubicin and cytarabine increases complete remission rate after a single course of induction treatment in acute myeloid leukemia. Multicenter, phase III study.

Holowiecki J, Grosicki S, Robak T, Kyrcz-Krzemien S, Giebel S, Hellmann A, Skotnicki A, Jedrzejczak WW, Konopka L, Kuliczkowski K, Zdziarska B, Dmoszynska A, Marianska B, Pluta A, Zawilska K, Komarnicki M, Kloczko J, Sulek K, Haus O, Stella-Holowiecka B, Baran W, Jakubas B, Paluszewska M, Wierzbowska A, Kielbinski M, Jagoda K; Polish Adult Leukemia Group (PALG).

Leukemia. 2004 May;18(5):989-97.

PMID:
14999298
41.

Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribine.

Robak T, Blonski JZ, Gora-Tybor J, Kasznicki M, Konopka L, Ceglarek B, Komarnicki M, Lewandowski K, Hellmann A, Lewandowski K, Moskwa A, Dmoszyńska A, Sokołowska B, Dwilewicz-Trojaczek A, Tomaszewska A, Sułek K, Całbecka M.

Eur J Cancer. 2004 Feb;40(3):383-9.

PMID:
14746857
42.

[Autologous hematopoietic stem cell transplantation for the treatment of aggressive non-Hodgkin's lymphoma. The experience of Polish lymphoma research group].

Hołowiecki J, Giebel S, Walewski J, Krawczyk-Kuliś M, Hellmann A, Skotnicki A, Dmoszyńska A, Romejko J, Czyz J, Jurczak W, Kachel Ł, Wojnar J, Stella-Hołowiecka B, Saduś-Wojciechowska M, Sułek K, Jedrzejczak W, Robak T, Mariańska B, Szczylik C, Warzocha K.

Pol Arch Med Wewn. 2003 Aug;110(2):863-8. Polish.

PMID:
14682225
43.

High-dose chemotherapy with autologous stem cell transplantation is an effective treatment of primary refractory Hodgkin's disease. Retrospective study of the Polish Lymphoma Research Group.

Czyz J, Hellmann A, Dziadziuszko R, Hansz J, Goździk J, Hołowiecki J, Stella-Hołowiecka B, Kachel Ł, Knopińska-Posłuszny W, Nagler A, Meder J, Walewski J, Lampka E, Sułek K, Sawicki W, Lange A, Forgacz K, Suchnicki K, Pacuszko T, Skotnicki A, Mensah P, Jurczak W, Kuliczkowski K, Wróbel T, Mazur G, Dmoszyńska A, Wach M, Robak T, Warzocha K.

Bone Marrow Transplant. 2002 Jul;30(1):29-34.

44.

First cases of acute human granulocytic ehrlichiosis in Poland.

Tylewska-Wierzbanowska S, Chmielewski T, Kondrusik M, Hermanowska-Szpakowicz T, Sawicki W, Sułek K.

Eur J Clin Microbiol Infect Dis. 2001 Mar;20(3):196-8.

PMID:
11347671
45.

[Evaluation of nephrologic "risk" in a newly diagnosed case of plasma cell dyscrasias from personal material (1994-2000)].

Zelichowski G, Raczka A, Sułek K, Wańkowicz Z.

Pol Merkur Lekarski. 2000 Dec;9(54):830-3. Polish.

PMID:
11255649
46.

Impaired skin microcirculation and blood rheology in patients with monoclonal gammapathy.

Szulkowska E, Sułek K, Kraj M, Budziszewska K, Zygocki K.

Clin Hemorheol Microcirc. 1999;21(2):105-12.

PMID:
10599594
47.

[Diagnosis of the increase of lymph nodes in the abdominal cavity].

Hałka J, Sułek K.

Wiad Lek. 1999;52(3-4):196-201. Review. Polish.

PMID:
10499032
48.

[Examination of skin microcirculation with laser-Doppler flowmetry in patients with essential hypertension].

Zygocki K, Skrobowski A, Wasak-Szulkowska E, Cwetsch A, Kubik L, Cholewa M, Sułek K.

Pol Merkur Lekarski. 1999 Feb;6(32):73-5. Polish.

PMID:
10337175
49.

[Five cases of acquired pure red cell aplasia].

Rzepecki P, Zygocki K, Sułek K, Betiuk B, Czajka T, Szulkowska E.

Wiad Lek. 1998;51(5-6):298-302. Polish.

PMID:
9737198
50.

[Changes in the quality of life influenced by treatment of primary arterial hypertension].

Gralec M, Piusińska-Macoch A, Cholewa M, Sułek K.

Pol Merkur Lekarski. 1997 Jan;2(7):28-31. Polish.

PMID:
9296895

Supplemental Content

Support Center